HER2-positive Breast Cancer Registry
Public ClinicalTrials.gov record NCT06603597. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Study identification
- NCT ID
- NCT06603597
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 27, 2024 (Actual)
- Primary completion
- Oct 2044 (Estimated)
- Completion
- Oct 2044 (Estimated)
- Last update posted
- Jul 17, 2026
2024 – 2044
United States locations
- U.S. sites
- 6
- U.S. states
- 2
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| KUCC - Indian Creek | Overland Park | Kansas | 66211 | Active, not recruiting |
| KUCC - Overland Park | Overland Park | Kansas | 66215 | Active, not recruiting |
| KUCC - Briarcliff | Westwood | Kansas | 66205 | Active, not recruiting |
| KUCC - Olathe | Westwood | Kansas | 66205 | Active, not recruiting |
| The University of Kansas Cancer Center | Westwood | Kansas | 66205 | Recruiting |
| KUCC - Lee's Summit | Lee's Summit | Missouri | 64064 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06603597, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2026 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06603597 live on ClinicalTrials.gov.